maxibar 98.45%w/w %w/w powder for oral suspension
bracco uk limited - barium sulfate - powder for oral suspension - 98.45%w/w %w/w
prohance, 279.3 mg/ml, solution for injection, 20 ml vial
bracco international b.v. - gadoteridol - solution for injection - 279.3 milligram(s)/millilitre - paramagnetic contrast media; gadoteridol
gastromiro 612.4mg/ml oral or rectal solution
bracco imaging spa - iopamidol - oral/rectal solution - 612.4 milligram(s)/millilitre - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopamidol
maxibar 98.45% w/w powder for oral suspension
bracco imaging spa - barium sulfate - powder for oral suspension - 98.45%w/w percent weight/weight - barium sulfate containing x-ray contrast media; barium sulfate with suspending agents
multihance, 0.5m solution for injection
bracco imaging spa - gadobenate dimeglumine - solution for injection - 0.5 mole(s)/litre - paramagnetic contrast media; gadobenic acid
niopam 150, solution for injection, glass bottles
bracco imaging spa - iopamidol - solution for injection - 150 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopamidol
niopam 200, solution for injection, glass bottles
bracco imaging spa - iopamidol - solution for injection - 200 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopamidol
niopam 300, solution for injection, glass bottles
bracco imaging spa - iopamidol - solution for injection - 300 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopamidol
niopam 340, solution for injection, glass bottles
bracco imaging spa - iopamidol - solution for injection - 340 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopamidol
niopam 370, solution for injection, glass bottles
bracco imaging spa - iopamidol - solution for injection - 370 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopamidol